Profound Medical
PROFProfound Medical Corp. is a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue.
Earnings
Next report
Aug 6, 2026 (In 1 week)Valuation & ratios
Segments
Competitors
By market cap
By revenue growth
By net margin
Profile
Profound Medical Corp. is a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. Its core value proposition lies in combining real-time MRI visualization with robotically-driven ultrasound and closed-loop temperature feedback to provide customizable, precise treatments that minimize side effects compared to traditional surgery or radiation.
A specialized player in the incision-free ablation market, leveraging a unique transurethral approach for prostate care and strategic compatibility with major MRI manufacturers.
Questions, answered.
- What is Profound Medical's market cap?
- Profound Medical (PROF) has a market capitalization of $266.4M and trades on NASDAQ.
- What is Profound Medical's revenue and profitability?
- Profound Medical generated $18.8M in trailing twelve-month revenue with a net loss of $38.9M, representing a net margin of -206.8%. Gross margin stands at 71.1%. These figures are based on the Q1 2026 filing.
- Who are Profound Medical's competitors?
- Profound Medical's key competitors include Intuitive Surgical, TriSalus Life Sciences, Inc. Common Stock, GLOBUS MEDICAL INC, and others. These companies compete in similar markets and product categories.
- Who does Profound Medical partner with?
- Profound Medical's notable partners include Philips, Siemens Healthineers, GE Healthcare.
- Where is Profound Medical headquartered?
- Profound Medical is headquartered in Canada and employs approximately 131 people. It has been publicly traded since 2016.
